Jeffrey A. Bailey - Mar 9, 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Chief Executive Officer, Director
Signature
Jeffrey A Bailey
Stock symbol
BDSI
Transactions as of
Mar 9, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 07:08 AM
Previous filing
Jan 31, 2022
Next filing
Mar 22, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +5.33K +5.34% $0.00 105K Mar 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Restricted Stock Units Options Exercise $0 -5.33K -50% $0.00 5.33K Mar 9, 2022 Common Stock 5.33K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023.